Arcadia Biosciences Inc

NASDAQ RKDA

Data sourced from iex and EODHD
Download Data

Arcadia Biosciences Inc Total Assets for the Trailing 12 Months (TTM) ending March 31, 2024: USD 16.05 M

Arcadia Biosciences Inc Total Assets is USD 16.05 M for the Trailing 12 Months (TTM) ending March 31, 2024, a -47.23% change year over year. Total Assets is the total value of all assets owned by a company, representing its resources.
  • Arcadia Biosciences Inc Total Assets for the Trailing 12 Months (TTM) ending March 31, 2023 was USD 30.41 M, a -21.62% change year over year.
  • Arcadia Biosciences Inc Total Assets for the Trailing 12 Months (TTM) ending March 31, 2022 was USD 38.80 M, a -45.20% change year over year.
  • Arcadia Biosciences Inc Total Assets for the Trailing 12 Months (TTM) ending March 31, 2021 was USD 70.80 M, a 119.55% change year over year.
  • Arcadia Biosciences Inc Total Assets for the Trailing 12 Months (TTM) ending March 31, 2020 was USD 32.25 M, a 34.23% change year over year.
NASDAQ: RKDA

Arcadia Biosciences Inc

CEO Ms. Pamela Haley
IPO Date May 15, 2015
Location United States
Headquarters 202 Cousteau Place, Davis, CA, United States, 95618
Employees 21
Sector Consumer Defensive
Industry Packaged foods
Description

Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief, and SoulSpring. The company was incorporated in 2002 and is headquartered in Dallas, Texas.

Similar companies

SENEA

Seneca Foods Corp A

NA

NA

BRID

Bridgford Foods Corporation

NA

NA

StockViz Staff

September 16, 2024

Any question? Send us an email